AB 1575 was introduced which revises the Medical Marijuana Regulation and Safety Act (MMRSA) to improve implementation of the regulatory framework, and ease the transition for existing operators, local governments, and the general public. AB 1575 is follow-up legislation to MMRSA to strengthen its original intent and goals. The regulatory framework balances local control with many of the needs of existing medical marijuana businesses. The bill established a licensing structure that prioritizes the protections of patients, the public, and the environment, and local control.
Allowance of For-Profit Model
- The bill explicitly allows for medical marijuana businesses to operate for-profit, not-for-profit, or under any combination thereof. It also clarifies that existing collectives may operate for profit.
Refinements to Licenses
- AB 1575 clarifies testing standards, requiring all testing to be done on medicine in the form in which the patient will be consuming it.
- The bill also creates a license for a non- traditional dispensary, allowing for dispensaries that operate without traditional storefronts for public access.
Access to Banking
- AB 1575 requires the Board of Equalization (BOE) to form an advisory group of stakeholders to address access of medical marijuana businesses to banking.
- Requires BOE to submit a report to the Legislature with its findings.
Research and Development
- The bill allows for research institutions and businesses to access limited amounts of medical marijuana for research purposes.
- Guidelines for research and development will be established by the Bureau of Medical Marijuana Regulation.